对转基因植物进行一次风险评估
Muffy Koch1, Jaylee DeMond1, Matthew G Pence1
1Simplot Plant Sciences, J. R. Simplot Company, Boise, ID, United States.
Frontiers in bioengineering and biotechnology
|August 4, 2025
概括
简化转基因植物监管需要采取全球风险评估方法. 协调审查减少了冗余,使开发商受益,并确保更广泛地获得转基因植物的优势.
科学领域:
- 农业生物技术 农业生物技术
- 环境科学环境科学
- 食品安全法规 食品安全法规
背景情况:
- 监管机构在评估转基因植物安全方面拥有超过30年的经验.
- 目前对转基因植物进行的国家风险评估是多余的,对开发商和政府资源造成了重大负担.
- 进口或种植许可证的重复安全审查是不必要的,因为它们不会改变已批准的转基因产品的安全概况.
研究的目的:
- 提出对转基因植物的统一全球风险评估模型,以提高监管效率.
- 倡导在各国之间分享风险评估摘要,以避免重复评估.
- 确定简化监管流程的步骤,包括对低风险特征的全球批准系统.
主要方法:
- 对转基因植物风险评估现有监管实践的分析.
- 提出基于国际标准的全球风险评估框架.
- 讨论协调监管审查和批准的战略.
主要成果:
- 全球风险评估模型可以显著减少监管冗余和负担.
- 分享评估摘要有助于有效的审查流程,同时保持国家监督.
- 协调加速了批准,可能扩大了获得转基因植物好处的机会.
结论:
- 采用对转基因植物进行单一的全球风险评估是一个可行的和有益的策略.
- 简化监管流程,包括对低风险特征的全球审查,对于创新至关重要.
- 协调的风险评估将使更广泛,更公平地获得转基因植物提供的优势.
相关概念视频
Transgenic Plants
7.4K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
7.4K
What is Genetic Engineering?
75.5K
Overview
75.5K
Plant Breeding and Biotechnology
19.7K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
19.7K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K


